Denali Therapeutics Inc (NASDAQ:DNLI)

31.38
Delayed Data
As of 3:59pm ET
 -0.32 / -1.01%
Today’s Change
20.24
Today|||52-Week Range
39.43
+12.84%
Year-to-Date

Today’s Trading

Previous close31.70
Today’s open31.32
Day’s range30.78 - 31.74
Volume10,475
Average volume (3 months)778,373
Market cap$4.3B
Data as of 3:59pm ET, 02/06/2023

Growth & Valuation

Earnings growth (last year)-466.28%
Earnings growth (this year)-6.98%
Earnings growth (next 5 years)-11.02%
Revenue growth (last year)-85.50%
P/E ratioNM
Price/Sales111.38
Price/Book4.03

Competitors

 Today’s
change
Today’s
% change
CRSPCRISPR Therapeutics ...+0.24+0.43%
----
ZLABZai Lab Ltd-1.09-2.72%
ARWRArrowhead Pharmaceut...-3.24-8.82%
Data as of 4:00pm ET, 02/06/2023

Financials

Next reporting dateFebruary 27, 2023
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$48.7M
Annual profit (last year)-$290.6M
Net profit margin-597.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts